Neoantigen is a protein produced by mutant gene, which is only expressed in tumor cells. It
is an ideal target for therapeutic tumor vaccines. Although synthetic long peptide (SLP) …

As one of novel hallmarks of cancer, lipid metabolic reprogramming has recently been
becoming fascinating and widely studied. Lipid metabolic reprogramming in cancer is …

Hepatitis B protein x (HBx) has been reported to promote tumorigenesis in hepatitis B virus
(HBV)-related hepatocellular carcinoma (HCC), but the mechanism awaits further …

Abstract Background Circular RNAs (circRNAs) and N6-methyladenosine (m6A) have been
shown to play an increasingly critical role in the development of different cancers. However …

Abstract N6-methyladenosine (m6A) is considered as the most common and important
internal transcript modification in several diseases like type 2 diabetes, schizophrenia and …

RNA N 6-methyladenosine (m6A) modification is one of the principal post-transcriptional
modifications and plays a dynamic role in testicular development and spermatogenesis …

Drug resistance is perhaps the greatest obstacle in improving outcomes for cancer patients,
leading to recurrence, progression and metastasis of various cancers. Exploring the …

Cancer therapy resistance (CTR) is the development of cancer resistance to multiple
therapeutic strategies, which severely affects clinical response and leads to cancer …

Head and neck squamous cell carcinoma ranks seventh in incidence of malignant tumours
in the world. Although there are treatments including surgery, radiotherapy and …

Mycotoxins can induce cell cycle disorders, cell proliferation, oxidative stress, and apoptosis
through pathways such as those associated with MAPK, JAK2/STAT3, and Bcl-w/caspase-3 …